Study Oversells HIFU Benefits, Especially in Low-Risk PCaStudy Oversells HIFU Benefits, Especially in Low-Risk PCa
Dr Gerald Chodak disputes the conclusions of a study comparing HIFU therapy with brachytherapy for patients with low or intermediate-risk prostate cancer. Medscape Urology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
More News: Brachytherapy | Cancer | Cancer & Oncology | Hematology | High Intensity Focused Ultrasound Therapy | Prostate Cancer | Study | Urology & Nephrology